Jelmyto Kit
Product Images NDC 72493-103

Product Visual Gallery

This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Jelmyto (NDC 72493-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Urogen Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Jelmyto 01)

Chemical structure of mitomycin, the active ingredient in JELMYTO. The diagram shows rings, functional groups, and stereochemistry typical of the mitomycin molecule.*

FDA Label Image

Image (Jelmyto 02)

JELMYTO kit by UroGen Pharma, Inc. shown open with two larger bottles and one smaller vial inside. The packaging is a rectangular box with a hinged lid containing these three containers typically used for preparation or administration of mitomycin.*

FDA Label Image

Image (Jelmyto 03)

Two black and white text panels labeled 'PI' and 'IFP,' which appear to represent printed informational documents or inserts related to the prescription drug JELMYTO (mitomycin). The panels contain blocks of text and lines resembling paragraphs and headings, indicating they are likely prescribing information and patient information leaflets.*

FDA Label Image

Image (Jelmyto 04)

FDA Label Image

Image (Jelmyto 05)

Illustration showing components of the JELMYTO kit from UroGen Pharma, Inc., including three TEVADAPTOR vial adaptors, three TEVADAPTOR syringe adaptors HF, one Luer lock connector, and one UroGen Pharma chilling block.*

FDA Label Image

Image (Jelmyto 06)

FDA Label Image

Image (Jelmyto 07)

The image shows two containers forming a kit for JELMYTO, a human prescription drug by UroGen Pharma, Inc. The top container appears to be a small vial, while the bottom is a larger bottle, consistent with a kit dosage form. Specific labels and text are not legible in the image.*

FDA Label Image

Image (Jelmyto 08)

An instructional illustration showing a medical kit component, including a syringe and vial setup, likely related to the preparation or administration of JELMYTO (mitomycin) KIT by UroGen Pharma, Inc.*

FDA Label Image

Image (Jelmyto 09)

An instructional diagram showing how to connect a vial to a gas cylinder or similar apparatus, with arrows indicating the sequence of steps for assembly or attachment. No product label or text is visible.*

FDA Label Image

Image (Jelmyto 10)

An instructional illustration showing a hand holding and preparing a medical vial or bottle, with arrows indicating steps to connect or remove a component, possibly part of the JELMYTO kit administration process.*

FDA Label Image

Image (Jelmyto 11)

An instructional line drawing showing a hand holding a vial with a rubber stopper that is being pierced by a syringe needle. A dashed elliptical line below the vial suggests motion or placement guidance, likely demonstrating vial preparation or injection technique.*

FDA Label Image

Image (Jelmyto 12)

JELMYTO kit packaging label showing the proprietary name JELMYTO with active ingredient mitomycin. Labeled as a human prescription drug. The label displays the UroGen Pharma, Inc. logo and includes directions for use along with storage and handling information. The packaging emphasizes the product as a kit format.*

FDA Label Image

Image (Jelmyto 13)

JELMYTO kit vial containing mitomycin as the active ingredient, manufactured by UroGen Pharma, Inc. The vial is brown with a white label area and a sealed white cap, used for prescription drug preparation.*

FDA Label Image

Image (Jelmyto 14)

FDA Label Image

Image (Jelmyto 15)

JELMYTO kit packaging label featuring a primarily black and white schematic outline of the product container with a distinctive valve and nozzle on top. The image does not show additional text or dosage details.*

FDA Label Image

Image (Jelmyto 16)

JELMYTO kit syringe illustration showing a pre-filled syringe with a white barrel and blue plunger. The syringe is depicted without additional packaging or labeling text, representing the dosage form of the prescription drug mitomycin by UroGen Pharma, Inc.*

FDA Label Image

Image (Jelmyto 17)

An illustration of a closed-loop tubing system with connectors, likely used for the administration or preparation of a pharmaceutical product. The tubing appears coiled with a clamp or connector at the top.*

FDA Label Image

Image (Jelmyto 18)

An instructional illustration showing a device likely used for drug administration or preparation, consisting of a plunger mechanism with a handle on one end and a hollow chamber. The image appears to depict the internal and external structure and function of the device components, possibly related to the JELMYTO mitomycin kit by UroGen Pharma, Inc.*

FDA Label Image

Image (Jelmyto 19)

An illustration shows a rectangular container filled with multiple small cubes, resembling ice cubes in a tray. The image is a simple black and white line drawing, likely indicating preparation or storage related to the product.*

FDA Label Image

Image (Jelmyto 20)

An instructional illustration showing a container of ice cubes with a vial immersed in it, accompanied by a clock graphic indicating a 10-minute duration, likely representing a cooling or thawing step for a medication vial.*

FDA Label Image

Image (Jelmyto 21)

An instructional diagram showing a syringe with a purple barrel and a vial stopper being pierced by the syringe needle. A green arrow points downward indicating the motion of inserting or drawing medication. To the left is a clock icon displaying "4 min," suggesting a four-minute wait or timing related to this step.*

FDA Label Image

Image (Jelmyto 22)

An instructional illustration showing a gloved hand using the JELMYTO administration kit. It depicts the insertion of a component labeled 'Clutch' into the device, demonstrating proper assembly or preparation technique.*

FDA Label Image

Image (Jelmyto 23)

An instructional illustration showing a gloved hand turning and pushing parts of a medical device or applicator, likely related to the preparation or administration of JELMYTO (mitomycin) KIT. The arrows indicate rotational and linear actions needed to operate the device.*

FDA Label Image

Image (Jelmyto 24)

Illustration showing a gloved hand attaching or assembling a component labeled 'Clutch' onto a syringe-like medical device, likely part of the JELMYTO kit. The image demonstrates a step in preparing or using the drug delivery system.*

FDA Label Image

Image (Jelmyto 25)

An instructional illustration showing hands wearing gloves assembling or preparing a JELMYTO kit, which includes a syringe attached to a blue and gray device. A circular arrow and a timer indicating 1 minute suggest a step involving rotation or mixing for one minute.*

FDA Label Image

Image (Jelmyto 26)

An instructional illustration showing the assembly of components for the JELMYTO kit by UroGen Pharma, Inc. It depicts a hand attaching a cap or applicator to a syringe-like device, likely part of the medication preparation or administration process for this mitomycin-containing human prescription drug kit.*

FDA Label Image

Image (Jelmyto 27)

An instructional diagram showing the assembly or connection of a small vial or container to a larger bottle or apparatus, with an arrow indicating the direction of attachment or flow from the smaller piece on top to the larger base component.*

FDA Label Image

Image (Jelmyto 28)

An instructional illustration showing a hand holding and operating a two-part drug delivery kit, likely for JELMYTO (mitomycin) KIT by UroGen Pharma, Inc. The image depicts the process of connecting or activating the device using arrows indicating movement directions.*

FDA Label Image

Image (Jelmyto 29)

An illustration showing two syringes partially submerged in containers filled with ice. The image appears to depict the proper storage or handling of injectable medication under refrigerated conditions, likely related to the preparation or preservation of the drug.*

FDA Label Image

Principal Display Panel (Kit Carton)

An instructional diagram showing two close-up steps involving hands and a syringe. The first step depicts a hand using a tool or needle to pierce a sealed vial or container. The second step shows a hand holding a syringe with a winged infusion set (butterfly needle) attached, preparing for use. The illustration likely relates to the preparation or administration process for JELMYTO (mitomycin) Kit by UroGen Pharma, Inc.*

FDA Label Image

Principal Display Panel (40 mg Vial Label)

Packaging label for JELMYTO (mitomycin) pyelocalyceal solution single-dose carton. The kit, distributed by UroGen Pharma, Inc., includes 2 vials of mitomycin for pyelocalyceal solution at 40 mg per vial and 1 vial of sterile hydrogel. The label features storage instructions and pharmacist reconstitution warnings, with branding and barcodes visible on the carton.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

JELMYTO (mitomycin) for pyelocalyceal solution 40 mg per vial single-dose vial label. Contains instructions for pharmacy preparation, storage conditions of 20°C to 25°C with permitted excursions, and warnings about use. Distributed by UroGen Pharma, Inc., Princeton, NJ. Includes a barcode and lot/expiration fields.*

FDA Label Image

Jelmyto 33

Label for JELMYTO sterile hydrogel single-dose vial containing mitomycin for pyelocalyceal solution preparation. The vial volume is 20 mL. Label includes storage conditions, dosing instructions, lot and expiration placeholders, and distributor information: UroGen Pharma, Inc., Princeton, NJ. Barcode and NDC 72493-102-20 shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.